Elpis Hatziagorou

Affiliations: 
Aristotle University of Thessaloniki, Thessaloniki, Greece 
Area:
cystic fibrosis, bronchoscopy, PCD, non-CF bronchiectasis
Google:
"Elpis Hatziagorou"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kerem E, Orenti A, Adamoli A, et al. (2024) Cystic fibrosis in Europe: improved lung function & longevity: reasons for cautious optimism, but challenges remain. The European Respiratory Journal
Fouzas S, Kogias C, Gioulvanidou M, et al. (2023) Low-frequency oscillometry indices to assess ventilation inhomogeneity in CF patients. Pediatric Pulmonology
Hatziagorou E, Avramidou V, Gioulvanidou M, et al. (2022) Pulmonary exacerbations, airway pathogens, and long-term course of lung clearance index in children and young adults with cystic fibrosis. Pediatric Pulmonology
Hatziagorou E, Manika K, Kyrvasili SS, et al. (2022) Pulmonary medication adherence among children and adults with cystic fibrosis: Is there an association with disease severity? Pediatric Pulmonology
Kampouras A, Hatziagorou E, Kalantzis T, et al. (2021) The Fitter the Better? Cardiopulmonary Exercise Testing Can Predict Pulmonary Exacerbations in Cystic Fibrosis. Children (Basel, Switzerland). 8
Hatziagorou E, Kampouras A, Avramidou V, et al. (2021) Toward the Establishment of New Clinical Endpoints for Cystic Fibrosis: The Role of Lung Clearance Index and Cardiopulmonary Exercise Testing. Frontiers in Pediatrics. 9: 635719
Hatziagorou E, Miloglou A, Nousia L, et al. (2020) P340 Adherence to physiotherapy, mental health and quality of life among children with cystic fibrosis Journal of Cystic Fibrosis. 19
Hatziagorou E, Manika K, Kyrvasili S, et al. (2020) P338 Is pulmonary medication adherence affected by disease severity among adult patients with cystic fibrosis Journal of Cystic Fibrosis. 19
Hatziagorou E, Kyrvasili S, Kouroukli E, et al. (2020) P213 Long-term effect of lumacaftor/ivacaftor on patients aged over 6 years with cystic fibrosis homozygous for F508del-CFTR Journal of Cystic Fibrosis. 19
Hatziagorou E, Mantsiou C, Kouroukli E, et al. (2020) WS06.1 Clinical value of Lung Clearance Index among patients with cystic fibrosis Journal of Cystic Fibrosis. 19
See more...